cost. In a meta-analysis of open tibial shaft fractures, unionrelated reoperation rates ranged from 4% to 48% 1 . Similarly high rates have been reported for closed fractures 2 , and a previous study from our institution demonstrated a surgical revision rate of 35% 3 . Thus, there is a need for adjuvant therapies to optimize fracture-healing and to prevent the need for revision surgery.
Since it was shown to induce osteogenesis in a currentdependent manner in the 1950s 4, 5 , electromagnetic field stimulation has been widely used to accelerate fracture repair 6 . Several modalities have been developed to deliver the electromagnetic fields, including a noninvasive method in which time-varying magnetic fields that are applied externally are utilized to induce electrical fields within bone 7, 8 . In vivo studies have shown that electromagnetic fields reduce osteoclast resorption, increase rates of osteoid formation, and stimulate angiogenesis 5 . In a randomized clinical trial of delayed unions of the tibial shaft, Sharrard showed a benefit in terms of radiographic progression of union when fractures that were treated with an active pulsed electromagnetic field device were compared with those that were treated with an inactive device 9 . Other trials have shown that it is an effective modality for the conservative treatment of long-bone nonunions [10] [11] [12] . Animal studies and clinical trials involving femoral and tibial osteotomies have also demonstrated accelerated healing 13, 14 . While this suggests that electromagnetic stimulation has the potential to optimize fracture repair processes in the acute setting, no evidence from randomized trials is available to evaluate the use of pulsed electromagnetic field stimulation following acute fractures.
The aim of this pragmatic randomized trial was to determine whether pulsed electromagnetic field stimulation reduces the rate of secondary surgical procedures needed to promote union of acute tibial shaft fractures in adults within twelve months. Additional objectives of the trial were to evaluate whether adjuvant pulsed electromagnetic field stimulation improved radiographic union within six months and patientreported functional outcomes at twelve months.
Materials and Methods

Study Design
W e conducted a prospective, double-blind randomized trial at six metropolitan trauma centers in New South Wales, Australia, between August 2005 and December 2008. All sites were teaching hospitals affiliated with universities. Approval of the study protocol was obtained from each of the local human research ethics committees. The trial was registered at clinicaltrials.gov (NCT00127725). Skeletally mature patients over the age of eighteen years who presented at a participating center with a diaphyseal fracture of the tibia (AO/OTA type 42) 15 were candidates for inclusion in the study. Patients were excluded if they were unable to consent or if the fracture had intra-articular extension or was pathological. As a safety precaution, pregnant women and individuals with implanted pacemakers or defibrillators were also excluded.
Randomization and Blinding
Electromagnetic stimulation was administered through the EBI Bone Healing system (Biomet, Fair Lawn, New Jersey), an external device worn over the fracture site. Prior to trial commencement, a collection of seventy pulsed electromagnetic field devices, thirty-five active and thirty-five inactive, were numbered by a statistician at the National Health and Medical Research Council Clinical Trials Centre. The statistician also generated the randomization sequence by the process of minimization, with weight being given to two characteristics: recruiting center and whether the fracture was open or closed. During the hospital stay, eligible patients were identified and were approached by a designated research officer at each site following acute treatment, including irrigation and debridement in the case of open fractures. After written consent was obtained, the researcher telephoned the external center to allocate a device number for the patient. The external center was otherwise not involved in the trial, and researchers were unaware of the random sequence, ensuring allocation concealment. A Biomet sales representative was contacted to fit the patient for the device and to educate the patient about the device. In patients with bilateral fractures, both fractures were assigned to the same group. Active and inactive devices were indistinguishable externally in terms of appearance and functionality, which ensured the blinding of patients, care providers, outcome collectors, and data analysts until trial completion. Once treatment was concluded, the devices were collected from the patients and were added to the pool of available devices for randomization to new patients.
Interventions
The EBI Bone Healing system consists of a flexible coil that is strapped to the leg over the fracture site, regardless of whether the patient has a plaster or fiberglass splint. The coil is attached with a cord to a mobile, battery-powered device. Active devices generated an electromagnetic field at 90°to the tibial shaft. Placebo devices were identical but were completely inactive. Patients were provided with verbal and written instructions to wear the assigned device over the fracture site for ten hours daily for twelve weeks. The devices were applied within two weeks after the injury. Initial patient care, including surgery and mobilization protocols, was otherwise unaltered and was at the discretion of the treating surgeon. Surgeons were not asked to refrain from secondary surgical procedures within any time point. Compliance was measured by means of the device's internal recording system, which provided information about the number of hours of usage. Patients were routinely contacted within two weeks after fitting of the device in order to increase compliance, which was defined as an average daily use of more than six hours.
Primary Outcome
The primary outcome was the rate of secondary surgery (consisting of intramedullary nail dynamization, revision fixation, and/or bone-grafting) that was performed to promote union within twelve months after the injury. Surgery to promote union of fractures that initially had been treated nonoperatively was regarded as a primary outcome. The decision to operate was made at the discretion of the treating consultant surgeon, who was blinded to treatment allocation.
Secondary Outcomes
Secondary outcomes included (1) surgical revision to promote union within three and six months; (2) surgical revision for any indication within three, six, and twelve months; (3) radiographic union within six months (defined as union of three of four cortices on anteroposterior and lateral radiographs); (4) functional outcomes at twelve months, measured with use of the validated 80-point Lower Extremity Functional Scale; and (5) health status at twelve months, measured with use of the Physical Component Summary Score of the Short Form-36 health survey (using the norm for the United States in 1998). Radiographs were assessed independently by two consultant trauma orthopaedic surgeons who were blinded to patient treatment group and who had five to fifteen years of experience. Interobserver agreement on classification was expressed with use of the kappa statistic, and disagreements were subsequently resolved by means of discussion.
Data Collection
Data were collected on four occasions-during admission and at three, six, and twelve months after the injury. Baseline patient demographics, injury characteristics, and primary management details were collected by the treating team in each of the recruitment centers. At three, six, and twelve months, questionnaires were mailed to both the patients and their surgeons. Treating surgeons were asked about the nature of and indication for any secondary surgical procedure performed. Patient questionnaires included the Short Form-36 (SF-36) and Lower Extremity Functional Scale surveys in addition to an inquiry regarding the execution of any secondary procedures. To increase response rates, patients were contacted via telephone with the option to complete the questionnaire orally. Operation reports and clinical notes were appraised if there were uncertainties about whether the operation was conducted to promote union.
Statistical Analysis
Comparison of categorical variables (surgical rates and radiologic union) between the active and placebo groups was performed with use of the chi-squared test, and the results were expressed with risk ratios and corresponding 95% confidence intervals (CI). Comparison of continuous variables (functional scores) was performed with use of unpaired t tests, and the results were expressed as mean differences and corresponding 95% CIs. Multiple regression was performed to account for the potential confounders of age, sex, comorbidity (cardiopulmonary disease, renal disease, diabetes, cirrhosis, stroke, arthritis, peripheral vascular disease, cancer), open grade (Gustilo classification) 16, 17 , smoking, mechanism of injury (fall, sports, vehicle, other), and hospital. First, univariate regression was conducted for each variable. Potential confounders (p < 0.25) were included in multivariate analysis, and the level of significance was set at p < 0.05 for all analyses. Main results were analyzed according to intention to treat. For the primary outcome, we also conducted three a priori analyses: (1) a per-protocol analysis, in which compliant patients in the active group were compared with patients in the placebo group and noncompliant patients in the active group; (2) a subgroup analysis of compliant patients in the active and placebo groups; and (3) a subgroup analysis of open and closed fractures. We also performed an exploratory analysis on the predictors of noncompliance with the device.
Sample Size Calculation
With no previous data on pulsed electromagnetic field stimulation for acute tibial fractures, we based our sample size calculation on economic considerations. We determined that, to justify the cost of each pulsed electromagnetic field unit, we would need to detect a 40% decrease in the surgical revision rate from 30% to 18% (based on a previous report from the administering institution) 3 . To detect this difference with 80% power, allowing for 20% loss to follow-up, we would require 340 participants.
Source of Funding
Biomet Australia provided the devices used in this trial. Sales representatives from Biomet Australia assisted in the fitting of devices and the education of patients. No external funding was received from any source in support of this study, which was internally funded by the Orthopaedic Department at Liverpool Hospital. The authors of the present study have not and will not receive any personal benefit, financial or otherwise, that may impact the findings of this study.
Results
Participant Flow and Baseline Characteristics
A t the primary study site, 223 patients were eligible. Of these, 111 refused participation, and 112 patients were recruited. An additional 147 patients were recruited from the other five participating centers. Thus, a total of 259 participants with 264 fractures were randomized in this study. Figure 1 depicts patient flow after recruitment. Data from 218 patients (overall follow-up rate, 84%) were available for analysis.
Baseline patient demographics, fracture characteristics, and treatment were similar between the groups (Table I ). The patients who were recruited were predominantly male (82%), with a mean age of thirty-nine years. Vehicle-related accidents (43%) and falls (33%) were the chief mechanisms of injury. Open fractures represented 28% of the total. Seventy-two percent of the fractures were treated with intramedullary nailing. The remainder were treated with plating (15%), closed reduction (10%), and external fixation (2%).
Participant compliance with the prescribed treatment was moderate, with an average use of 6.2 hours per day. This value was lower than anticipated, but compliance was comparable between the two cohorts. Patients with open fractures (odds ratio [OR] = 0.44; 95% CI = 0.23 to 0.81; p = 0.009) and smokers (OR = 0.30; 95% CI = 0.16 to 0.55; p < 0.001) were less likely to be compliant, whereas patients with cast treatment (OR = 2.98; 95% CI = 1.17 to 7.56; p = 0.02) were more likely to be compliant. Age, sex, hospital, mechanism of injury, other concomitant injury, comorbidity, and intramedullary nailing or plating were not associated with compliance. The baseline characteristics of participants who were not analyzed were similarly homogenous and did not differ from those of the analyzed patients. Because of slower-than-expected recruitment, patient recruitment was ceased in December 2008 after discussion with all stakeholders in the trial, and therefore the predetermined target of 340 patients was not reached. Data analysis was not performed prior to the decision to stop the trial.
Operations for Delayed or Nonunion
Sixteen patients (15%) in the active group and fifteen patients (13%) in the placebo group experienced a primary outcome event (secondary surgery because of delayed or nonunion) within twelve months. The difference was not significant (risk ratio [RR] = 1.02; 95% CI = 0.91 to 1.14; p = 0.72). Similarly, no significant benefits of pulsed electromagnetic field stimulation were found for secondary operations within three or six months (Table II) .
In a subgroup analysis, open fractures were associated with a higher operation rate for the treatment of delayed union or nonunion than closed fractures. However, there was no significant difference in terms of the primary outcome event between the patients managed with the active treatment and those managed with the placebo treatment within either the closed subgroup (RR = 1.02; 95% CI = 0.93 to 1.13; p = 0.65) or the open subgroup (RR = 0.94; 95% CI = 0.72 to 1.35; p = 0.94). A subgroup analysis that included only compliant patients in the active (n = 48; 45%) and placebo (n = 52; 46%) groups also demonstrated no difference in terms of secondary operation rates (Table III) .
We also conducted a per-protocol analysis in anticipation of low compliance rates. There were six cases (12%) of reoperation for union in the active, compliant group and twenty-six cases (15%) of reoperation for union in the combined placebo and active, noncompliant group (RR = 0.97; 95% CI = 0.86 to 1.10; p = 0.61) (Table IV ). An analysis in which compliant patients in the active group Flow diagram for the patients who were analyzed for the primary outcome (secondary operation for delayed union or nonunion) at twelve months.
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were compared with only patients in the placebo group showed similar results (Table V) . Logistic regression with the secondary operation rate as the outcome variable did not identify any characteristics with a significant association.
Overall Secondary Operations
Thirty-one patients in the active group (29%) and thirty patients in the placebo group (27%) had a secondary procedure (for any reason) within twelve months after the injury. The difference was not significant (RR = 1.03; 95% CI = 0.88 to 1.22; p = 0.69). Similarly, no differences were found within three and six months after the injury (Table VI) .
Radiographic Union
Overall, only 111 patients (43%) provided radiographs at three months and ninety-three patients (36%) provided radiographs at six months. Interobserver agreement for the classification of radiographs at six months was moderate (kappa = 0.62). There were no differences between the active and placebo groups with regard to radiographic union at three or six months (Table VII) .
Functional Outcomes
At twelve months, the mean SF-36 Physical Component Summary scores for the active and placebo groups were 44.9 and 48.0, respectively (mean difference, 23.1; 95% CI = 20.25 to 6.41; p = 0.07). The mean Lower Extremity Functional Scale scores for the active and placebo groups were 48.9 and 54.3, respectively (mean difference, 25.4; 95% CI = 20.63 to 11.51; p = 0.08).
Adverse Events
One patient in the placebo group died within the first twelve months of follow-up because of lung carcinoma. No adverse events related to the use of the pulsed electromagnetic field device were reported.
Discussion
T he mechanism by which electromagnetic field stimulation accelerates fracture-healing is uncertain; it is believed that the pulsed electromagnetic field enhances the differentiation of mesenchymal stem cells into a chondrogenic lineage through upregulation of cytokines, transforming growth factor-beta (TGF-b), and members of the bone morphogenetic protein (BMP) family 18 . In vitro cultures of human osteoblast-like cells stimulated with a pulsed electromagnetic field for eight hours a day for four days demonstrated significant increases in TGF-b. In vivo chick and rat cultures demonstrated severalfold increases in BMP-2 and BMP-4 mRNA.
We found that pulsed electromagnetic field stimulation, utilized as an adjunct to standard care in the treatment of acute tibial fractures, did not decrease the rate of secondary surgical procedures. This trend was mirrored in the supplementary analyses designed to exaggerate the effect of the pulsed electromagnetic field (our subgroup analysis of compliant patients and the per-protocol analysis). We found, in accordance with the current literature, that open fractures are a predictor for an additional surgical procedure to promote union 2, 19, 20 . Our overall tibial revision rates are comparable with currently reported rates and follow the trend that over half are performed prior to six months 2, 20 . We studied a heterogeneous population in comparison with those that have been studied in previous, smaller clinical trials of pulsed electromagnetic field stimulation. Our study group had variable baseline patient and fracture characteristics that were evenly distributed between the active treatment and placebo groups We consider our population and interventions to be reflective of cases typically managed in modern trauma centers. 
Screening data were only available from the primary research site, where approximately half of all eligible patients were recruited, while the rest declined consent. Accurate screening data were not available from the other research sites and consequently were not reported. Although this is a potential threat to external validity, the anecdotal experiences of researchers at these sites were similar to those at the central site.
We found that pulsed electromagnetic field stimulation provided no benefit in terms of radiographic union at three and six months. As we relied on patients to provide radiographs via prepaid envelopes for the assessment of radiographic union, poor follow-up for this outcome was realized. Although radiographic union is a widely reported outcome in fracture research, we argue that this outcome is relatively less important, for a number of reasons. First, radiographic union, by definition, is not patient-centered and consequently may not be important to patients. Second, the diagnosis of osseous union often requires information obtained from a history and physical examination, which must be interpreted in the context of each patient. Third, the diagnosis of radiographic union is subject to high levels of interobserver disagreement. We achieved only moderate agreement, which is similar to other reports of reliability 21 . Other scales of radiographic union have been developed 22 , but their practical use in large clinical trials remains to be seen.
The results of this trial are not aligned with the results of previous clinical studies on the use of pulsed electromagnetic field stimulation for the treatment of fresh fractures and osteotomies. Fontanesi et al. described a significant reduction in time to union and index of union in a study of forty fresh closed or Grade-I open tibial fractures, from an average of 110 days to eighty-six days 23 . Close scrutiny of the methodologies reveals that confounders such as smoking and compliance were not examined, potentially rendering the two nonrandomized cohorts incomparable. Pulsed electromagnetic field stimulation was also demonstrated to enhance union at the sites of femoral and tibial osteotomies 13, 14 . An evaluation of thirty-one femoral osteotomies demonstrated greater bone density and trabecular bridging in the treated group 14 , and a double-blinded randomized controlled trial on tibial osteotomies demonstrated that electromagnetic stimulation had positive effects on healing 13 . At sixty days postoperatively, 72% of patients in the active group were found to be in the advanced stages of healing compared with 26% treated with placebo 13 . It should be highlighted that both of these outcomes were based on precise radiographic assessments; therefore, a clinical benefit may not be inferred from these results. The present pragmatic trial was not designed to show whether pulsed electromagnetic field stimulation reduces the time to radiographic union, but instead focused on the patientcentered outcome of secondary surgery. Unlike the SPRINT trial 2 , surgeons were not restricted from secondary surgery at any time point. It is unlikely that this resulted in any bias in the presence of adequate blinding.
Our results also differ from the efficacy found in delayed unions and nonunions, although the behavior of fresh fractures is too dissimilar to be directly comparable. We postulate that although pulsed electromagnetic field stimulation has demonstrated the capacity to enhance fracture repair at the site of established nonunions, its effect in relation to the optimal spontaneous osteogenic environment of fresh fractures is insufficient to produce a clinically apparent improvement. Conversely, in suboptimal repair conditions, as encountered with delayed unions and nonunions, pulsed electromagnetic field stimulation may improve fracture repair to produce a measureable clinical impact. In a recent meta-analysis of pulsed electromagnetic field stimulation for long-bone fractures, Mollon et al. found no randomized trials involving acute fractures 6 . In addition, their pooled analysis did not show evidence supporting the use of pulsed electromagnetic field stimulation, primarily because of the heterogeneous results of the small trials, and the authors recommended larger trials of sound design.
Strengths and Limitations
The strengths of the present study are the robust methodology and pragmatic design. Multiple surgeons and centers participated in this trial. Bias was reduced through blinding of all individuals involved in the trial (including the participants, investigators, and surgeons), and the central randomization system ensured allocation concealment. The chief limitation resulted from our inability to achieve our target sample-size population of 340 participants in a reasonable time frame. In addition, the operation for nonunion event rate was less than what was anticipated according to the power calculation. This may have been due to the recruitment of patients with lowenergy injuries from other (smaller) centers or an improvement in the standard of treatment. Our post hoc power calculation demonstrated that, with 270 patients and a control event rate of 15%, the present study was powered to find a 67% relative difference in event rates. Considering the narrow confidence intervals found in our results, it is likely we would have detected this benefit, if it exists. A smaller benefit (within our confidence intervals) cannot be detected, but it is unlikely that a small benefit (within our confidence intervals) would have been clinically relevant. Nevertheless, to our knowledge, our population of 259 participants represents the largest clinical trial on electromagnetic stimulation. Moreover, the minor differences in reoperation rates favored the placebo group, such that it is unlikely that the recruitment of an additional eighty-one participants would have produced a clinically important effect favoring the active treatment. We also noted a substantially lower compliance rate as compared with those in previous studies on self-administered electromagnetic stimulation. In our study, most devices were fitted by a company representative, who offered education about the device to patients. Patients were also encouraged to use the device in follow-up calls in the first two weeks. While the reasons for noncompliance were not measured, anecdotal responses from participants indicated that the device was too cumbersome to use for the long periods prescribed. Therefore, we believe that these compliance rates are an accurate reflection of general patient attitudes and responses to this device, particularly in the setting of a trial involving only a 50% chance of wearing an active device. This study was not designed to detect differences in subgroups based on fracture treatment, and the number of patients managed with methods other than intramedullary nails was too small to identify any meaningful differences. The low rate of follow-up for radiograph assessment has also been noted, such that conclusions regarding radiographic healing cannot be made from our results.
Implications
A recent Canadian survey of orthopaedic surgeons demonstrated that the use of bone growth stimulators in clinical practice is extensive in the treatment of both complicated and uncomplicated fractures 24 . The cost of these devices to the health-care system is substantial 6 . While this prospective randomized trial was not designed to detect earlier radiographic union, we failed to demonstrate any clinical or functional benefit to justify the use of pulsed electromagnetic field stimulation as an adjunct to the standard treatment of acute tibial fractures. We do not recommend the use of pulsed electromagnetic field stimulation for the treatment of acute tibial shaft fractures. n
